Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants

Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03772301
Collaborator
(none)
1,000
36

Study Details

Study Description

Brief Summary

"Hoarding "is a common behavior among Holocaust survivors and is related to the traumatic events they have experienced, and we assume that storage behavior and eating disorders are related to future generations of Holocaust survivors.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants
    Anticipated Study Start Date :
    Jan 1, 2019
    Anticipated Primary Completion Date :
    Jan 1, 2022
    Anticipated Study Completion Date :
    Jan 1, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Group 1

    At least 200 Jewish Holocaust survivors of the first generation living in Germany and Israel - an equal number in each country

    Group 2

    The second generation, whose parents lived in Europe during the Second World War, now live in Germany (originating from Western and Eastern Europe) - at least 200 participants.

    Group 3

    Third generation of Jewish Holocaust survivors who participated in the first phase, currently living in Germany and Israel - at least 200 participants including at least 100 subjects in each country. These are adults only. The research program does not include children and adolescents

    Outcome Measures

    Primary Outcome Measures

    1. Hoarding [Three years]

      Questionnaire that will follow behaviour over generations

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Jewish Holocaust survivors living in Germany and Israel who have expressed their written and written consent to participate in monitoring and testing, and who are able to answer the research questionnaires.

    • Their direct offspring and their children (second and third generation)

    1. The control population - non-Jewish subjects who are not the descendants of Holocaust survivors living in Germany who have expressed their written and oral consent to participate in monitoring and testing and who are able to answer the research questionnaires and whose parents were not imprisoned in the camps second.
    Exclusion Criteria:
    • (Participants who do not agree to participate (did not sign informed consent form

    • Respondents who are unable to answer interviewer questions

    • Non-Jewish subjects whose parents were in camps (ie prisoner camps, labor camps, etc.) during the second war.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Hillel Yaffe Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hillel Yaffe Medical Center
    ClinicalTrials.gov Identifier:
    NCT03772301
    Other Study ID Numbers:
    • HYMC-0083-18
    First Posted:
    Dec 11, 2018
    Last Update Posted:
    Dec 11, 2018
    Last Verified:
    Dec 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 11, 2018